Clinical Trial Results Phase 2 Trial (Published in the New England Journal of Medicine, 2023) The landmark phase 2 trial of retatrutide, published by Jastreboff et al
What is the difference between a standard and an extended-stability compounded formulation
Interestingly, we only observed the negative effects of thiazolidinediones and sulfonylureas on GLP-1 M effectiveness in our final predictive model, which was built using all the features shown in Supplemental Fig
Programs aim to boost collagen and elastin, reduce inflammation, and promote wound healing with antioxidant, healthy-aging supportfrequently included in cosmetic and recovery-focused regimens
But how do get the meds to them
In 46,177 adults aged 65 and older, starting a GLP-1 was associated with an 11% higher rate of fragility fracture than starting a different diabetes medication, and the signal sat almost entirely in the 65-to-75 band